Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDIORG Medicamen Organics Ltd. Pharma · SME | SAROJA Saroja Pharma Industries India Ltd. Pharma · SME | ARVEE Arvee Laboratories (India) Limited Pharma · Small | NGLFINE NGL Fine-Chem Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 13 | 49 | 21 | 35 |
| Verdict | OVERVALUED | FAIR VALUE | OVERVALUED | WATCHLIST |
| Style | Distress Watch | Deep Value | OVERVALUED | WATCHLIST |
| Piotroski | 4/9 | 6/9 | 5/9 | 8/9 |
| Valuation | 5/30 | 30/30 | 0/30 | 0/30 |
| Growth | 10/25 | 15/25 | 11/25 | 6/25 |
| Quality | 0/20 | 0/20 | 0/20 | 11/20 |
| Balance Sheet | 4/15 | 7/15 | 11/15 | 10/15 |
| Cash Flow | 0/10 | 1/10 | 3/10 | 3/10 |
| Price | ₹20 | ₹33.95 | ₹163.57 | ₹2,820.7 |
| P/E | — | 8.43 | 69.60 | 34.10 |
| P/B | 0.89 | 0.79 | 5.21 | 4.98 |
| ROE | -13.70% | 9.83% | 7.78% | 15.70% |
| ROCE | -10.70% | 13.00% | 7.92% | 17.00% |
| Debt / Equity | 0.50 | 0.83 | 0.03 | 0.33 |
| FCF Yield | — | — | 0.22% | — |
| Dividend Y | — | — | — | 0.07% |
| Altman Z | 1.52 | 2.91 | 7.99 | 6.95 |
| Promoter % | 59.73% | 73.02% | 73.50% | 72.73% |
| Mkt Cap (₹Cr) | 25.60 | 13.60 | 176.00 | 1640.00 |
| Graham # | — | ₹62.44 | ₹39.86 | ₹966.61 |
| Fair PE | 42.0 | 42.0 | 42.0 | 6.2 |
| MoS % | — | +80.0% | -69.3% | -482.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDIORG15
SAROJA86
ARVEE96
NGLFINE138